Redmile Group, LLC Gritstone Bio, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 5,107,732 shares of GRTS stock, worth $2.4 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,107,732
Previous 5,755,075
11.25%
Holding current value
$2.4 Million
Previous $14.8 Million
78.59%
% of portfolio
0.21%
Previous 0.58%
Shares
21 transactions
Others Institutions Holding GRTS
# of Institutions
83Shares Held
37.5MCall Options Held
1.46MPut Options Held
168K-
Vanguard Group Inc Valley Forge, PA4.64MShares$2.18 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.45MShares$2.09 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA3.56MShares$1.67 Million4.9% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL3.46MShares$1.63 Million0.01% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M3.23MShares$1.52 Million0.0% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $34.3M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...